|
A customer via government agency reported that the patient underwent vitreoretinal surgery consisting of a 25-gauge pars plana vitrectomy, membrane peel, silicone oil removal, endolaser photocoagulation, and the use of perfluoro-n-octane (pfo) to manage the underlying retinal condition.Postoperatively, the patient experienced cardiac arrest in the recovery room, resulting in death.The event was reported to be associated with the use of perfluoron from two different lot numbers.No further details were provided and additional information was requested.
|